BioVaxys Technology Email Formats

Biotechnology Research • Toronto, Ontario, Canada • 1-10 Employees

BioVaxys Technology Email Formats

BioVaxys Technology uses 1 email format. The most common is {last name}{last name} (e.g., doedoe@biovaxys.com), used 100% of the time.

Format	Example	Percentage
{last name}{last name}	doedoe@biovaxys.com	100%

Key Contact at BioVaxys Technology

Craig Loverock

Director

Company overview

Headquarters	146 Thirtieth Street Canada, Suite 100, Etobicoke, Ontario M8W 3D4 , CA
Phone number	+16042628835
Websites	biovaxys.com genix.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Drug Delivery, Cancer, Oncology, Cancer Vaccines, Immunotherapeutics, Melanoma, Vaccine, Virology, Ovarian Cancer, Personalized Immunotherapy, Lipid Delivery
Founded	2020
Employees	1-10
Socials

About BioVaxys Technology

BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF, FR:5LB), formerly BioVaxys LLC, is a British Columbia-registered clinical-stage biotechnology company dedicated to improving patient lives with novel immunotherapies based on our DPX™ immune-educating delivery technology platform and our HapTenix© neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase IIb clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© neoantigen tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. BioVaxys is capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore BioVaxys Technology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-12-10	14	$405,000
2024-02-08	14	$1,200,000
2024-03-09	14	$501,500
2024-06-03	14	$917,900
2024-04-22	14	$1,300,000
2024-12-18	14	$709,900
2025-01-13	14	$175,000
2025-02-10	14	$537,500
2025-05-01	14	$42,000
2025-06-30	11	$2,200,000
2025-06-30	14	$2,200,000
2025-10-16	16	$243,800

Funding Insights

$10,432,600

Total funding amount

$243,800

Most recent funding amount

Number of funding rounds

BioVaxys Technology Tech Stack

Discover the technologies and tools that power BioVaxys Technology's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Webflow

Page builders

core-js

JavaScript libraries

LottieFiles

Miscellaneous

Google Analytics

Analytics

Frequently asked questions

BioVaxys Technology is located in Toronto, Ontario, CA.

You can reach BioVaxys Technology at +16042628835.

BioVaxys Technology was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

BioVaxys Technology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

BioVaxys Technology has raised a total of $10,432,600 across 12 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at BioVaxys Technology

Craig Loverock

Director

4.8

40,000 users